These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7216430)

  • 21. Lytic sensitivity of Actinobacillus actinomycetemcomitans Y4 to lysozyme.
    Iacono VJ; Boldt PR; MacKay BJ; Cho MI; Pollock JJ
    Infect Immun; 1983 May; 40(2):773-84. PubMed ID: 6404833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What's new in lysozyme research? Always a model system, today as yesterday.
    Jollès P; Jollès J
    Mol Cell Biochem; 1984 Sep; 63(2):165-89. PubMed ID: 6387440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva.
    Tortosa M; Cho MI; Wilkens TJ; Iacono VJ; Pollock JJ
    Infect Immun; 1981 Jun; 32(3):1261-73. PubMed ID: 6166567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of bacterial aggregation induced by saliva, lysozyme, and zinc.
    Golub EE; Cheruka J; Boosz B; Davis C; Malamud D
    Infect Immun; 1985 Apr; 48(1):204-10. PubMed ID: 3980083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysozyme-mediated aggregation and lysis of the periodontal microorganism Capnocytophaga gingivalis 2010.
    Iacono VJ; Zove SM; Grossbard BL; Pollock JJ; Fine DH; Greene LS
    Infect Immun; 1985 Feb; 47(2):457-64. PubMed ID: 3967924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.
    Laible NJ; Germaine GR
    Infect Immun; 1985 Jun; 48(3):720-8. PubMed ID: 3922894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nasal secretions in allergic disease of the nose.
    Bachert C; Becker W; Ganzer U
    Arch Otorhinolaryngol; 1989; 246(4):173-82. PubMed ID: 2688620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of salivary lysozyme, lactoperoxidase, and lactoferrin in diabetic hamsters.
    Muratsu K; Morioka T
    Infect Immun; 1985 May; 48(2):389-94. PubMed ID: 2580790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence of Streptococcus sanguis to hydroxyapatite coated with lysozyme and lysozyme-supplemented saliva.
    Tellefson LM; Germaine GR
    Infect Immun; 1986 Mar; 51(3):750-9. PubMed ID: 2419251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of bacteriolytic activity in the oral cavity by nutritionally variant streptococci.
    Pompei R; Caredda E; Piras V; Serra C; Pintus L
    J Clin Microbiol; 1990 Jul; 28(7):1623-7. PubMed ID: 2380384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of bactericidal and bacteriolytic activities of poly-D-lysine and lysozyme by chitotriose and ferric iron.
    Tompkins GR; O'Neill MM; Cafarella TG; Germaine GR
    Infect Immun; 1991 Feb; 59(2):655-64. PubMed ID: 1987082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Killing of gram-negative bacteria by lactoferrin and lysozyme.
    Ellison RT; Giehl TJ
    J Clin Invest; 1991 Oct; 88(4):1080-91. PubMed ID: 1918365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.
    MacKay BJ; Denepitiya L; Iacono VJ; Krost SB; Pollock JJ
    Infect Immun; 1984 Jun; 44(3):695-701. PubMed ID: 6724693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lysozyme and inorganic anions on the morphology of Streptococcus mutans BHT: electron microscopic examination.
    Cho MI; Holt SC; Iacono VJ; Pollock JJ
    J Bacteriol; 1982 Sep; 151(3):1498-507. PubMed ID: 7107557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of histatin-5 and lysozyme on the ability of Streptococcus mutans to form biofilms in in vitro conditions.
    Krzyściak W; Jurczak A; Piątkowski J; Kościelniak D; Gregorczyk-Maga I; Kołodziej I; Papież MA; Olczak-Kowalczyk D
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1056-66. PubMed ID: 26400891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial mechanisms of lysozyme on Streptococcus mutans.
    Wang YB
    Zhonghua Ya Yi Xue Hui Za Zhi; 1990 Sep; 9(3):87-97. PubMed ID: 2135996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective antibacterial properties of lysozyme for oral microorganisms.
    Iacono VJ; MacKay BJ; DiRienzo S; Pollock JJ
    Infect Immun; 1980 Aug; 29(2):623-32. PubMed ID: 7216430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adsorption of lysozyme from human whole saliva by Streptococcus sanguis 903 and other oral microorganisms.
    Laible NJ; Germaine GR
    Infect Immun; 1982 Apr; 36(1):148-59. PubMed ID: 7076291
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.